Compare NICE Ltd (NICE) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
NICE Ltd vs Smith & Nephew plc — how do they compare? NICE Ltd trades at $94.34 (market cap $5.91B), while Smith & Nephew plc trades at $30.45 (market cap $12.64B). The key difference: Smith & Nephew plc is far larger — about 2.1× NICE Ltd's market cap, and Smith & Nephew plc pays a 2.57% dividend while NICE Ltd pays none. Which is the better fit depends on your goals.
| NICE | SNN | |
|---|---|---|
Market Cap | $5.91B | $12.64B |
Sector | Technology | Health |
52-Week High | $170.37 | $38.70 |
52-Week Low | $83.15 | $28.73 |
Enterprise Value | $5.69B | $15.41B |
Dividend Yield | — | 2.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About NICE Ltd
NICE Ltd. is a global leader in both enterprise software and cloud computing, specializing in customer experience and financial crime prevention solutions. The company's platform utilizes advanced analytics, AI, and automation to help organizations enhance customer interactions, ensure compliance, and combat fraud. NICE serves a diverse client base, including contact centers, financial institutions, and government agencies, by optimizing operations and improving service quality.
Read more on NICE →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
